The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patients.

Autor: Çağlayan D; Necmettin Erbakan University Faculty of Medicine, Department of Medical Oncology, Konya, Turkey., Koçak MZ; Necmettin Erbakan University Faculty of Medicine, Department of Medical Oncology, Konya, Turkey., Geredeli Ç; Okmeydanı Training & Research Hospital, Department of Medical Oncology, Istanbul, Turkey., Atcı MM; Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Medical Oncology, Istanbul, Turkey., Tatlı AM; Akdeniz University Faculty of Medicine, Department of Medical Oncology, Antalya, Turkey., Göksu SS; Akdeniz University Faculty of Medicine, Department of Medical Oncology, Antalya, Turkey., Eryılmaz MK; Necmettin Erbakan University Faculty of Medicine, Department of Medical Oncology, Konya, Turkey., Araz M; Necmettin Erbakan University Faculty of Medicine, Department of Medical Oncology, Konya, Turkey., Artaç M; Necmettin Erbakan University Faculty of Medicine, Department of Medical Oncology, Konya, Turkey.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024 Sep 24, pp. 1-7. Date of Electronic Publication: 2024 Sep 24.

The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.

Autor: Uğraklı M; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey. mugrakli@gmail.com., Koçak MZ; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Dinç G; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey., Genç TB; Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Çağlayan M; Department of Medical Oncology, Selçuk University, Konya, Turkey., Uğraklı S; Department of Medical Microbiology, Necmettin Erbakan University, Konya, Turkey., Hendem E; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Er MM; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Çağlayan D; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Eryılmaz MK; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Araz M; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey., Geredeli Ç; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey., Tatlı AM; Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Eren OÖ; Department of Medical Oncology, Selçuk University, Konya, Turkey., Artaç M; Meram Faculty of Medicine Department of Medical Oncology, Necmettin Erbakan University, 14280, Konya, Turkey.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Sep; Vol. 149 (11), pp. 9183-9189. Date of Electronic Publication: 2023 May 15.

The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.

Autor: Karaağaç M; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Geredeli Ç; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Yıldırım MS; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Altınok T; Department of Thoracic Surgery, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Dede İ; Department of Medical Oncology, Medical Faculty, Ankara University, Ankara, Turkey., İnal A; Department of Medical Oncology, Medical Faculty, Dicle University, Diyarbakir, Turkey., Zamani AG; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Kaya B; Department of Nuclear Medicine, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey., Demirkazık A; Department of Medical Oncology, Medical Faculty, Ankara University, Ankara, Turkey., Artaç M; Department of Medical Oncology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1248-1254.

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.

Autor: Karacin C; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey. cengizkaracin@yahoo.com., Oksuzoglu B; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Demirci A; Department of Medical Oncology, Sakarya University, Sakarya, Turkey., Keskinkılıç M; Department of Medical Oncology, Dokuz Eylül University, İzmir, Turkey., Baytemür NK; Department of Medical Oncology, Memorial Hospital, Ankara, Turkey., Yılmaz F; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Selvi O; Department of Medical Oncology, Okmeydanı Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey., Erdem D; Department of Medical Oncology, VM Medical Park Hospital, Samsun, Turkey., Avşar E; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Paksoy N; Department of Medical Oncology, Istanbul University Instıtue of Oncology, Istanbul, Turkey., Demir N; Department of Medical Oncology, Acıbadem Hospital, Kayseri, Turkey., Göksu SS; Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Türker S; Department of Medical Oncology, Zonguldak Hospital, Zonguldak, Turkey., Bayram E; Department of Medical Oncology, Çukurova University, Adana, Turkey., Çelebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Yılmaz H; Department of Medical Oncology, Adnan Menderes University, Aydın, Turkey., Kuzu ÖF; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Kahraman S; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Gökmen İ; Department of Medical Oncology, Trakya University, Edirne, Turkey., Sakin A; Department of Medical Oncology, Istanbul Medipol University Bahçelievler Hospital, Istanbul, Turkey., Alkan A; Department of Medical Oncology, Muğla Sıtkı Koçman University, Muğla, Turkey., Nayır E; Mersin Medical Park Hospital, Department of Medical Oncology, Mersin, Turkey., Uğraklı M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Acar Ö; Department of Medical Oncology, Celal Bayar University, Manisa, Turkey., Ertürk İ; Department of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Turkey., Demir H; Department of Medical Oncology, Afyonkarahisar Health Sciences University Hospital, Afyonkarahisar, Turkey., Aslan F; Department of Medical Oncology, Ankara Medical Park Hospital, Ankara, Turkey., Sönmez Ö; Department of Medical Oncology, Acıbadem University Maslak Hospital, Istanbul, Turkey., Korkmaz T; Department of Medical Oncology, Acıbadem University Maslak Hospital, Istanbul, Turkey., Celayir ÖM; Department of Medical Oncology, Acıbadem University Maslak Hospital, Istanbul, Turkey., Karadağ İ; Department of Medical Oncology, Hitit University Hospital, Çorum, Turkey., Kayıkçıoğlu E; Department of Medical Oncology, Süleyman Demirel University Hospital, Isparta, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Öktem İN; Department of Medical Oncology, Ersin Arslan Training and Research Hospital, Gaziantep, Turkey., Eren T; Department of Medical Oncology, UHS Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey., Erul E; Department of Medical Oncology, Hacettepe University Instıtue of Oncology, Ankara, Turkey., Mocan EE; Department of Medical Oncology, Ankara University, Ankara, Turkey., Kalkan Z; Department of Medical Oncology, Dicle University, Diyarbakır, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University, Elazığ, Turkey., Ergün Y; Batman Training and Research Hospital, Batman, Turkey., Akagündüz B; Department of Medical Oncology, Erzincan Binali Yıldırım University, Erzincan, Turkey., Karakaya S; Department of Medical Oncology, Atatürk Pulmonary Diseases Hospital, Ankara, Turkey., Kut E; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Teker F; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey., Demirel BÇ; Department of Medical Oncology, Pamukkale University, Denizli, Turkey., Karaboyun K; Department of Medical Oncology, Namık Kemal University, Tekirdağ, Turkey., Almuradova E; Department of Medical Oncology, Ege University, İzmir, Turkey., Ünal OÜ; UHS İzmir Tepecik Training and Research Hospital, İzmir, Turkey., Oyman A; Department of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul, Turkey., Işık D; Kocaeli Medical Park, Department of Medical Oncology, Kocaeli, Turkey., Okutur K; Department of Medical Oncology, Bahçelievler Memorial Hospital, Istanbul, Turkey., Öztosun B; Department of Medical Oncology, Istanbul Medeniyet University, Istanbul, Turkey., Gülbağcı BB; Department of Medical Oncology, Sakarya University, Sakarya, Turkey., Kalender ME; Department of Medical Oncology, Meddem Hospital, Isparta, Turkey., Şahin E; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Özdemir Ö; İzmir Bozyaka Training and Research Hospital, İzmir, Turkey., Selçukbiricik F; Department of Medical Oncology, Koç University, Istanbul, Turkey., Kanıtez M; Department of Medical Oncology, American Hospital, Istanbul, Turkey., Dede İ; Department of Medical Oncology, Mustafa Kemal University, Hatay, Turkey., Gümüş M; Department of Medical Oncology, Istanbul Medeniyet University, Istanbul, Turkey., Gökmen E; Department of Medical Oncology, Ege University, İzmir, Turkey., Yaren A; Department of Medical Oncology, Pamukkale University, Denizli, Turkey., Menekşe S; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Ebinç S; Department of Medical Oncology, Dicle University, Diyarbakır, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Instıtue of Oncology, Ankara, Turkey., İmamoğlu Gİ; Department of Medical Oncology, UHS Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey., Altınbaş M; Department of Medical Oncology, UHS Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey., Çetin B; Department of Medical Oncology, Süleyman Demirel University Hospital, Isparta, Turkey., Uluç BO; Department of Medical Oncology, Acıbadem University Maslak Hospital, Istanbul, Turkey., Er Ö; Department of Medical Oncology, Acıbadem University Maslak Hospital, Istanbul, Turkey., Karadurmuş N; Department of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Turkey., Erdoğan AP; Department of Medical Oncology, Celal Bayar University, Manisa, Turkey., Artaç M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Tanrıverdi Ö; Department of Medical Oncology, Muğla Sıtkı Koçman University, Muğla, Turkey., Çiçin İ; Department of Medical Oncology, Trakya University, Edirne, Turkey., Şendur MAN; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Oktay E; Department of Medical Oncology, Adnan Menderes University, Aydın, Turkey., Bayoğlu İV; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Paydaş S; Department of Medical Oncology, Çukurova University, Adana, Turkey., Aydıner A; Department of Medical Oncology, Istanbul University Instıtue of Oncology, Istanbul, Turkey., Salim DK; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Geredeli Ç; Department of Medical Oncology, Okmeydanı Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey., Yavuzşen T; Department of Medical Oncology, Dokuz Eylül University, İzmir, Turkey., Doğan M; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey., Hacıbekiroğlu İ; Department of Medical Oncology, Sakarya University, Sakarya, Turkey.

Publikováno v: BMC cancer [BMC Cancer] 2023 Feb 27; Vol. 23 (1), pp. 192. Date of Electronic Publication: 2023 Feb 27.

The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.

Autor: Çağlayan D; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. dilekcaglayan88@gmail.com., Koçak MZ; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Geredeli Ç; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey., Tatlı AM; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Göksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Eryılmaz MK; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Araz M; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Artaç M; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Feb; Vol. 79 (2), pp. 243-248. Date of Electronic Publication: 2022 Dec 15.